Viloxazine, a new approved drug for the treatment of attention deficit hyperactivity disorder in children
WU Bin-han
HE Xin
Machine-generated Keywords：
Publication Date：2022-05-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 836-839 )